Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma

Leukemia and Lymphoma

Volumn 48, Issue 11, 2007, Pages 2196-2203

  Abazis Stamboulieh, Danai ^a   Oikonomou, Pagona ^b   Papadoulis, Nikolaos ^c   Panayiotidis, Panayiotis ^d   Vrakidou, Efimia ^e   Tsezou, Aspasia ^a,b,f  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c GENERAL HOSPITAL OF LARISSA   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e Center of Radiation Oncology   (Greece)

^f INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

Interleukin 1; Multiple myeloma; Polymorphisms

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE CONTROL; GENETIC PREDISPOSITION; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GREECE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LINKAGE (GENETICS); MALE; MIDDLE AGED; MULTIPLE MYELOMA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36048987118     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701615892     Document Type: Article

References (51)

1. Jemal, A., Siegel, R. and Ward, E. (2006) Cancer statistics, 2006. CA Cancer J Clin, 56, pp. 106-130.
2. Kyle, R. A. and Lust, J. A. (1989) Monoclonal gammopathies of undetermined significance. Semin Hematol, 26, p. 176.
3. Mazur, G., Bogunia-Kubik, K., Wrobel, T., Karabon, L., Polak, M. and Kuliczkowski, K. (2005) IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immun Lett, 96, pp. 241-246.
4. Harousseau, J-L, Shaughnessy Jr, J. and Richardson, P. (2004) Multiple myeloma. Am Soc Hem Hematol, 1, pp. 237-256.
5. McCrea, A. P. and Morris, T. C. (1986) Concurrent familial myeloma in Northern Ireland. Cancer, 58, pp. 394-396.
6. Brown, L. M., Linet, M. S., Creenberg, R. S., Silverman, D. T., Hayes, R. B. and Swanson, G. M. (1999) Multiple myeloma and family history among blacks and whites in the US. Cancer, 85, pp. 2385-2390.
7. Grosbois, B., Jego, P., Attale, Payen, C., Rapp, M. J. and Fuzibet, J. G. (1999) Familial multiple myeloma: Report of fifteen families. Br J Haematol, 105, pp. 760-770.
8. Zheng, C., Huang, D., Liu, L., Glas, S Bergenbrant and Osterborg, A. (2001) Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int J Cancer, 95, pp. 184-188.
9. Zheng, C., Huang, D., Bergenbrant, S., Sundblad, A., Osterborg, A. and Bjorkholm, M. (2000) Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphism in multiple myeloma. Br J Haematol, 109, pp. 39-45.
10. Lauta, V. M. (2001) Interleukin-6 and the network of several cytokines in multiple myeloma: An overview of clinical and experimental data. Cytokine, 16, pp. 79-86.
11. Lauta, V. M. (2003) A review of the cytokine network in multiple myeloma: Diagnostic, prognostic and therapeutic implications. Cancer, 97, pp. 2440-2452.
12. Howell, W. M. and Rose-Jerilli, M. J. (2006) Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Familial Cancer, 5, pp. 143-149.
13. Howell, W. M. and Rose-Jerilli, M. J. (2007) Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr, 137, pp. 194-199.
14. Nicklin, M. J., Barton, J. L., Nguyen, M., FitzGerald, M. G., Duff, G. W. and Kornman, K. (2002) A sequenced based map of the nine genes of the human interleukin cluster. Genomics, 79, p. 718.
15. Arend, W. P., Malyak, M., Guthridge, C. J. and Gabay, C. (1998) Interleukin 1 receptor antagonist: A role in biology. Ann Rev Immunol, 16, p. 27.
16. Dinarello, C. A. (1996) Biological basis for interleukin-1 in disease. Blood, 87, p. 2095.
17. Dinarello, C. A. (1998) Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci, 856, pp. 1-11.
18. Cozzolino, F., Torcia, M., Aldinucci, D., Rubartelli, A., Miliani, A. and Shaw, A. R. (1989) Production of interleukin-1 by bone marrow myeloma cells. Blood, 74, p. 380.
19. Yamamoto, I., Kawano, M., Sone, T., Iwato, K., Tanaka, H. and Ishikawa, H. (1989) Production of interleukin-1β, a potent bone resorbing cytokine, by cultured human myeloma cells. Cancer Res, 49, p. 4242.
20. Torcia, M., Lucibello, M., Vannier, E., Fabiani, S., Miliani, A. and Guidi, G. (1996) Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. Exp Hematol, 24, pp. 868-874.
21. Lichtenstein, A., Berenson, J., Norman, D. and Zighelboim, J. (1989) Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. (Suppl. Blood), 74, p. 1266.
22. Carter, A., Merchav, S., Silvian-Draxler, I. and Tatarsky, I. (1990) The role of interleukin-1 and tumour necrosis factor-α in human multiple myeloma. Br J Haematol, 74, pp. 424-431.
23. Endres, S., Cannon, J. G., Ghorbani, R., Dempsey, R. A., Sisson, S. D. and Lonnemann, G. (1989) In vitro production of IL-1 beta, IL-1 alpha, TNF and IL-2 in healthy subjects: Distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol, 19, p. 2327.
24. Hall, S. K., Perregaux, D. G. and Gabel, C. A. (2004) Correlation of polymorphic variation in the promoter region of the interleukin-1_gene with secretion of interleukin-1∥otein. Arthritis Rheum, 50, p. 1976.
25. Hume, M., Lahdenpahja, N. and Santtila, S. (1998) Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med, 30, p. 469.
26. Omar, E M El, Carrington, M. and Chow, W. H. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404, pp. 398-402.
27. Demeter, J., Messer, G., Ramisch, S., Mee, J. B., Giovine, F. S. and Schmid, M. (1996) Polymorphisms within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokine Mol Ther, 2, pp. 239-242.
28. Mellstedt, H., Bjorkholm, M. and Holm, G. (1977) Intermittent melphalan and prednisolone therapy in plasma cell myeloma. Acta Med Scand, 202, pp. 5-9.
29. Pettersson, D., Mellstedt, H., Holm, G. and Bjorkholm, M. (1981) Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage. Scand J Haemat, 27, pp. 287-293.
30. Calvo, J., Martinez, N., Extragibel, A., Calleja, S. and Saez-Torres, C. (2002) Alellic frequence of polymorphic variation of cytokine gene (IL1A, IL1b, IL1RA, IL6, IL10, IL12p40 and INFG) in Spanish population. Immunologia, 21, p. 76.
31. Kornman, K. S., Crane, A., Wang, H. Y., Giovine, F S di, Newman, M. G. and Pirk, F. W. (1997) The inteleukin 1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol, 42, pp. 72-77.
32. Howell, W. M., Turner, S. J., Theaker, J. M. and Bateman, A. C. (2003) Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenetics, 30, pp. 409-414.
33. Cantagrel, A., Navaux, F. and Loubet-Lescoulie, P. (1999) Interleukin-1 beta, interleukin-1 receptor antagonist, interleukin-4 and interleukine-10 gene polymorphisms: Relationship to occurrence and severity to rheumatoid arthritis. Arhritis Rheum, 42, pp. 1093-1100.
34. Endler, G., Marculescu, R., Starkl, P., Binder, A., Geishofer, G. and Müller, M. (2006) Polymorphsims in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia. Clin Chem, 52, pp. 511-514.
35. Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. and Russel, R. G. (1983) An interleukin 1 like factor stimulates bone resorption in vitro. Nature, 306, pp. 378-380.
36. Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D. and Mundy, G. R. (1998) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature, 319, pp. 516-518.
37. Chen, H., Wilkins, L. M., Aziz, N., Cannings, C., Wyllie, D. H. and Bingle, C. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genetics, 15, pp. 519-529.
38. Chiplunkar, S., Langhorne, J. and Kaufmann, S. H. (1986) Stimulation of B cell growth and differentiation by murine recombinant interleukin 1. J Immunol, 137, pp. 3748-3752.
39. Jandl, R. C., Flanagan, R. G. and Schur, P. H. (1988) Interleukin stimulation of human B-lumpoblast differentiation. Clin Immunol Immunopathol, 46, pp. 115-121.
40. Tatsuta, T., Cheng, J. and Mountz, J. D. (1996) Intracellular IL-1beta is an inhibitor of Fas-mediated apoptosis. J Microbiol, 157, pp. 3949-3957.
41. Hirsch, E., Irikura, V. M., Paul, S. M. and Hirsch, D. (1996) Functrions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA, 93, pp. 11008-11013.
42. Hurme, M. and Santtila, S. (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL 1Ra and IL-1 beta genes. Eur J Immunol, 46, pp. 115-121.
43. Bioque, G., Crusius, J. B., Koutroubakis, I., Bouma, G., Kostense, P. J. and Meuwissen (1995) Allelic polymorphisms in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol, 102, pp. 379-383.
44. Lai, J., Zhou, D., Xia, S., Shang, Y., Zhu, J. and Pan, J. (2006) Association of interleukin-1 gene cluster polymorphisms with ischemic stroke in a Chinese population. Neurol Ind, 54, pp. 366-369.
45. Jatoi, A., Nguyen, P. L., Foster, N., Sun, D., Stella, P. J. and Campbell, M. (2007) Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol, 5, pp. 41-46.
46. Migita, K., Maeda, Y., Abiru, S., Nakamura, M., Komori, A. and Miyazoe, S. (2007) Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection. J Hepatol, 46, pp. 381-386.
47. Lee, K. M., Park, S. K., Hamajima, N., Tajima, K., Choi, J. Y. and Noh, D. Y. (2006) Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res Treat, 96, pp. 197-202.
48. Carter, A., Merchav, S., Silvian-Draxler, I. and Tatarsky, I. (1990) The role of interleukin and tumor necrosis factor-a in human multiple myeloma. Brit J Haematol, 74, pp. 424-431.
49. de Capei, M Uboldi, Dametto, E., Fasano, M. E., Rendine, S. and Curtoni, S. E. (2003) Genotyping for cytokine polymorphisms: Allele frequencies in the Italian population. Eur J Immunogenetics, 30, pp. 5-10.
50. Marshall, S., McLaren, A. J., McKinney, E. F., Bird, T., Haldar, N. A. and Bunce, M. (2001) Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation, 71, pp. 469-476.
51. Nieters, A., Brems, S. and Becker, N. (2001) Cross-sectional study on cytokine polymorphisms, cytokine production after T-cell stimulation and clinical parameters in a random sample of German population. Hum Genetics, 108, pp. 241-246.